Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
RR-SRC| H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-OH
RR-SRC| H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-OH
CAS No. 81156-93-6
RR-SRC| H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-OH( ——— )
Catalog No. M40324 CAS No. 81156-93-6
RR-SRC is a substrate for src-tyrosine-specific protein kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 567 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRR-SRC| H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionRR-SRC is a substrate for src-tyrosine-specific protein kinase.
-
DescriptionTyrosine kinase substrate peptide
-
In VitroRR-SRC (0-1 mM; 48 h) inhibits proliferation of CTL clone.Cell Proliferation Assay Cell Line:CTL clone OE4 Concentration:0, 0.25, 0.5 and 1 mM Incubation Time:48 hResult:Inhibited the proliferation in a concentration-dependent manner.
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number81156-93-6
-
Formula Weight1519.66
-
Molecular FormulaC64H106N22O21
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Taffs RE, et al. Modulation of the effector functions of cytolytic T-lymphocytes with synthetic peptide inhibitors of protein kinases. J Pharm Sci. 1992 Jan;81(1):37-44.?
molnova catalog
related products
-
HG106
HG106, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene.
-
Nepitrin
Nepetin-7-glucoside has antioxidant activity in human HL6 cells assessed as reduction of cytochrome-c release, DPPH free radical scavenging activity, and inhibition of TPA-induced free radical formation.
-
Canertinib
Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo.
